Næste

Automatisk afspilning

Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival

3 Visninger • 07/10/23
Del
Indlejre
administrator
administrator
Abonnenter
0

The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning